123 related articles for article (PubMed ID: 27753657)
1. A Comparative Immunohistochemical Study of Epithelial Membrane Antigen and NHERF1/EBP50 in the Diagnosis of Ependymomas.
Nambirajan A; Sharma MC; Rajeshwari M; Kakkar A; Suri V; Sarkar C
Appl Immunohistochem Mol Morphol; 2018 Jan; 26(1):71-78. PubMed ID: 27753657
[TBL] [Abstract][Full Text] [Related]
2. NHERF1/EBP50 and NF2 as diagnostic markers for choroid plexus tumors.
Georgescu MM; Mobley BC; Orr BA; Shang P; Lehman NL; Zhu X; O'Neill TJ; Rajaram V; Hatanpaa KJ; Timmons CF; Raisanen JM
Acta Neuropathol Commun; 2016 May; 4(1):55. PubMed ID: 27229317
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity and specificity of epithelial membrane antigen staining patterns in ependymomas.
Hasselblatt M; Paulus W
Acta Neuropathol; 2003 Oct; 106(4):385-8. PubMed ID: 12898159
[TBL] [Abstract][Full Text] [Related]
4. NHERF1/EBP50 is an organizer of polarity structures and a diagnostic marker in ependymoma.
Georgescu MM; Yell P; Mobley BC; Shang P; Georgescu T; Wang SH; Canoll P; Hatanpaa KJ; White CL; Raisanen JM
Acta Neuropathol Commun; 2015 Mar; 3():11. PubMed ID: 25775275
[TBL] [Abstract][Full Text] [Related]
5. [Diagnostic use of D2-40 and annexin-1 in ependymal tumors].
Wang YF; Piao YS; Lu DH; Chen L; Wang W; Yang H; Wei LF
Zhonghua Bing Li Xue Za Zhi; 2011 Sep; 40(9):595-8. PubMed ID: 22177242
[TBL] [Abstract][Full Text] [Related]
6. Podoplanin is a potential marker for the diagnosis of ependymoma: a comparative study with epithelial membrane antigen (EMA).
Ishizawa K; Komori T; Shimada S; Hirose T
Clin Neuropathol; 2009; 28(5):373-8. PubMed ID: 19788053
[TBL] [Abstract][Full Text] [Related]
7. The immunophenotype of ependymomas.
Vege KD; Giannini C; Scheithauer BW
Appl Immunohistochem Mol Morphol; 2000 Mar; 8(1):25-31. PubMed ID: 10937045
[TBL] [Abstract][Full Text] [Related]
8. Epithelial differentiation with microlumen formation in meningioma: diagnostic utility of NHERF1/EBP50 immunohistochemistry.
Georgescu MM; Olar A; Mobley BC; Faust PL; Raisanen JM
Oncotarget; 2018 Jun; 9(47):28652-28665. PubMed ID: 29983887
[TBL] [Abstract][Full Text] [Related]
9. CD99 immunoreactivity in ependymoma.
Choi YL; Chi JG; Suh YL
Appl Immunohistochem Mol Morphol; 2001 Jun; 9(2):125-9. PubMed ID: 11396629
[TBL] [Abstract][Full Text] [Related]
10. Histological spectrum of ependymomas and correlation of p53 and Ki-67 expression with ependymoma grade and subtype.
Suri VS; Tatke M; Singh D; Sharma A
Indian J Cancer; 2004; 41(2):66-71. PubMed ID: 15318011
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical study of ependymal neoplasms: histological subtypes and glial and epithelial characteristics.
Kaneko Y; Takeshita I; Matsushima T; Iwaki T; Tashima T; Fukui M
Virchows Arch A Pathol Anat Histopathol; 1990; 417(2):97-103. PubMed ID: 1695040
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of Olig2, CD99, and EMA to differentiate oligodendroglial-like neoplasms.
Kurdi M; Eberhart C
Folia Neuropathol; 2021; 59(3):284-290. PubMed ID: 34628794
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical comparison of chordoma with chondrosarcoma, myxopapillary ependymoma, and chordoid meningioma.
Cho HY; Lee M; Takei H; Dancer J; Ro JY; Zhai QJ
Appl Immunohistochem Mol Morphol; 2009 Mar; 17(2):131-8. PubMed ID: 19521276
[TBL] [Abstract][Full Text] [Related]
14. [Immunohistochemical study for choroid plexus papillomas and ependymomas].
Kunishio K; Shiraishi T; Mishima N; Matsumi N; Satoh T; Matsumoto K; Furuta T; Nishimoto A; Taguchi K
Neurol Med Chir (Tokyo); 1991 Dec; 31(13):859-66. PubMed ID: 1726244
[TBL] [Abstract][Full Text] [Related]
15. Distribution of epithelial membrane antigen in normal and neoplastic human ependyma.
Uematsu Y; Rojas-Corona RR; Llena JF; Hirano A
Acta Neuropathol; 1989; 78(3):325-8. PubMed ID: 2763805
[TBL] [Abstract][Full Text] [Related]
16. Comparative immunohistochemical study of insulin-like growth factor II and insulin-like growth factor receptor type 1 in pediatric brain tumors.
Ogino S; Kubo S; Abdul-Karim FW; Cohen ML
Pediatr Dev Pathol; 2001; 4(1):23-31. PubMed ID: 11200487
[TBL] [Abstract][Full Text] [Related]
17. Roles of NHERF1/EBP50 in cancer.
Georgescu MM; Morales FC; Molina JR; Hayashi Y
Curr Mol Med; 2008 Sep; 8(6):459-68. PubMed ID: 18781953
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical study of CD99 and EMA expression in ependymomas.
Mahfouz S; Aziz AA; Gabal SM; el-Sheikh S
Medscape J Med; 2008 Feb; 10(2):41. PubMed ID: 18382710
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of histopathological ependymoma variants.
Neumann JE; Spohn M; Obrecht D; Mynarek M; Thomas C; Hasselblatt M; Dorostkar MM; Wefers AK; Frank S; Monoranu CM; Koch A; Witt H; Kool M; Pajtler KW; Rutkowski S; Glatzel M; Schüller U
Acta Neuropathol; 2020 Feb; 139(2):305-318. PubMed ID: 31679042
[TBL] [Abstract][Full Text] [Related]
20. Value and limits of immunohistochemistry in differential diagnosis of clear cell primary brain tumors.
Koperek O; Gelpi E; Birner P; Haberler C; Budka H; Hainfellner JA
Acta Neuropathol; 2004 Jul; 108(1):24-30. PubMed ID: 15108012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]